OVERVIEW

This live 1-hour virtual CME-certified activity will discuss the evidence-based Thyroid Nodule Management Pathway. The panelists, from Penn Medicine, will help address critical decision-making points along this patient-centered pathway for the Primary Care Provider. If you’ve ever asked yourself when is the right time to consult with an endocrinologist, we hope that you will participate. This activity will provide immediate key takeaways to your clinical practice.

TARGET AUDIENCE

PCPs, Ob/GYN, Endocrinology

LEARNING OBJECTIVES

After participating in this activity, the learner should be able to:

1. Apply evidence-based evaluation for patients with thyroid nodules
2. Illustrate the association of sonographic imaging with cancer risk and its application to FNA decision making
3. Describe the Bethesda cytology classification for reporting thyroid nodule FNA results and the indications for molecular testing.

Panelists:

• Kristen Kobaly, MD, Endocrinology- Moderator
• Zubair W. Baloch, MD, PhD-- Pathology and Laboratory Medicine, Endocrine Pathology
• Patrick Sayre, MD, Primary Care
• Jessica Berman, MD, Endocrinology
• Jill E. Langer, MD, Radiology
• Karthik Rajasekaran, MD, FACS Otorhinolaryngology

ACCREDITATION

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME).
Credits
AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance / Participation (1.00 hours)

For more information please visit the official event page.